The in vivo experimentsdemonstrated that upregulation of PCGEM1 strengthened the protective effects ofmontelukast sodium on pulmonary function by reducing airway hyperresponsiveness andincreasing FEV0.4/FVC. The gene discussed is PCGEM1; the disease is airway hyperresponsiveness.